This series was created for international firms who rely on foreign export markets for a substantial portion of their business or who might be threatened by foreign trade competition. The estimates given in this report were created using a methodology developed by and under the direct supervision of Professor Philip M. Parker, the Chair Professor of Management Science at INSEAD. The methodology relies on historical figures of economic growth and trade flows of some 150 countries for over 2,500 industrial or product categories. The figures should be seen as market estimates, as opposed to historical records, as these are projected for the current year of trade.
On the demand side, exporters and strategic planners approaching the world market face a number of questions. Which countries are supplying salicylic acid and its salts and esters? What is the dollar value of these imports? How much do the imports of salicylic acid and its salts and esters vary from one country to another? Do exporters serving the world market have similar market shares across the importing countries? Which countries supply the most exports of salicylic acid and its salts and esters? Which countries are buying their exports? What is the value of these exports and which countries are the largest buyers?
"Salicylic acid and its salts and esters" as a category is defined in this report following the definition given by the United Nations Statistics Division Classification Registry using the Standard International Trade Classification, Revision 3 (SITC, Rev. 3). The SITC code that defines "salicylic acid and its salts and esters" is 51393.
Our reports have been used by over 10K customers, including:
340 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- The global market for Osteoporosis Therapeutics is projected to reach US$13.3 billion by 2025, driven by rising awareness over the growing problem of osteoporosis and the ensuing emphasis on early diagnosis and treatment. With the percentage share of people aged 60 plus in the global population mix forecast...
125 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Clostridium Difficile Treatment Market to Reach $1.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Clostridium Difficile Treatment estimated at US$878.9 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 5.1% over the...
268 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Tuberculosis Therapeutics Market to Reach $1.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Tuberculosis Therapeutics estimated at US$979 Million in the year 2020, is projected to reach a revised size of US$1.3 Billion by 2027, growing at aCAGR of 3.6% over the period 2020-2027....
172 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Overactive Bladder (OAB) Therapeutics Market to Reach $3.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Overactive Bladder (OAB) Therapeutics estimated at US$3.2 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at aCAGR of 0.9%...
Nocturia (Genitourinary Disorders) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Drugs in Development, 2021, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined...
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Drugs in Development, 2021 Summary Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed...
Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021 Summary Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021 provides an overview of the Cartilage Degeneration pipeline landscape. The report provides comprehensive information on the therapeutics under...
Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 Summary Corneal Graft Rejection (Immunology) - Drugs in Development, 2021 provides an overview of the Corneal Graft Rejection pipeline landscape. The report provides comprehensive information on the therapeutics under development...
Edema (Cardiovascular) - Drugs in Development, 2021 Summary Edema (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Edema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Edema, complete with analysis by Stage...
Hemorrhagic Shock (Other Diseases) - Drugs in Development, 2021 Summary Hemorrhagic Shock (Other Diseases) - Drugs in Development, 2021 provides an overview of the Hemorrhagic Shock pipeline landscape. The report provides comprehensive information on the therapeutics under development for...
Therapy
Research And Development
Drug Development
World
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.